drugset / Trial / NCT03469999
Effect of Dysport Injections on Energy Expenditure and Walking Efficiency in Children With Cerebral Palsy
NaSingle-groupOpen-labelTreatment
Summary
This study aims to evaluate the efficacy of single event multi level chemoneurolysis with the abobotulinumtoxin A drug, Dysport®, on walking energy expenditure and gait in children with spastic diplegia cerebral palsy.
Timeline
- Start
- 2018-12-12
- Primary completion
- 2021-05-26
- Completion
- 2021-05-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 10 iu/kg | — |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 15 iu/kg | — |